ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients

Bibliographic Details
Main Authors: Dingxie Liu, Qiongyu Hao, Jieqing Li, Qun Li, Kun Wang, Qing Geng, Yutong Wu, Jaydutt V. Vadgama, Yong Wu
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Cancer Communications
Online Access:https://doi.org/10.1002/cac2.12296
_version_ 1828264488853307392
author Dingxie Liu
Qiongyu Hao
Jieqing Li
Qun Li
Kun Wang
Qing Geng
Yutong Wu
Jaydutt V. Vadgama
Yong Wu
author_facet Dingxie Liu
Qiongyu Hao
Jieqing Li
Qun Li
Kun Wang
Qing Geng
Yutong Wu
Jaydutt V. Vadgama
Yong Wu
author_sort Dingxie Liu
collection DOAJ
first_indexed 2024-04-13T04:26:02Z
format Article
id doaj.art-996d92ab73134f3c8c08ef9759281226
institution Directory Open Access Journal
issn 2523-3548
language English
last_indexed 2024-04-13T04:26:02Z
publishDate 2022-07-01
publisher Wiley
record_format Article
series Cancer Communications
spelling doaj.art-996d92ab73134f3c8c08ef97592812262022-12-22T03:02:31ZengWileyCancer Communications2523-35482022-07-0142766366710.1002/cac2.12296ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patientsDingxie Liu0Qiongyu Hao1Jieqing Li2Qun Li3Kun Wang4Qing Geng5Yutong Wu6Jaydutt V. Vadgama7Yong Wu8Bluewater Biotech LLC New Providence NJ 07974 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADepartment of Oncology Shanghai East Hospital School of Medicine Tongji University Shanghai 200123 P. R. ChinaDepartment of Breast Cancer Cancer Center Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences Guangzhou Guangdong 510080 P. R. ChinaDepartment of Thoracic Surgery Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. ChinaBluewater Biotech LLC New Providence NJ 07974 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USAhttps://doi.org/10.1002/cac2.12296
spellingShingle Dingxie Liu
Qiongyu Hao
Jieqing Li
Qun Li
Kun Wang
Qing Geng
Yutong Wu
Jaydutt V. Vadgama
Yong Wu
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
Cancer Communications
title ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_full ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_fullStr ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_full_unstemmed ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_short ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
title_sort zbed2 expression enhances interferon signaling and predicts better survival of estrogen receptor negative breast cancer patients
url https://doi.org/10.1002/cac2.12296
work_keys_str_mv AT dingxieliu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT qiongyuhao zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT jieqingli zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT qunli zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT kunwang zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT qinggeng zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT yutongwu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT jayduttvvadgama zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients
AT yongwu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients